The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Medical Device Affairs Outsourcing Market Between 2026 And 2030?
The medical device affairs outsourcing market has experienced substantial expansion over the past few years. Projections indicate its value will rise from $5.45 billion in 2025 to $5.85 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 7.3%. This historical expansion can be linked to several factors, including heightened regulatory complexities, the reliance on internal regulatory departments, an increasing volume of medical device approvals, the broadening of global medical device markets, and a heightened understanding of compliance-related risks.
The medical device affairs outsourcing market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $7.65 billion, demonstrating a compound annual growth rate (CAGR) of 6.9%. This growth during the projected timeframe stems from various factors, including the uptake of sophisticated regulatory software, an increase in outsourcing collaborations, a heightened emphasis on strategic regulatory foresight, the broadening of post-market surveillance initiatives, and the incorporation of AI and analytics to enhance regulatory effectiveness. Key trends for this period encompass a greater reliance by medical device firms on regulatory affairs outsourcing, an escalating need for cloud-based solutions for compliance and management, efforts to simplify clinical trial applications and regulatory filings, an expansion in quality management system (QMS) support offerings, and improved capabilities for post-market surveillance and risk evaluation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19571&type=smp
Which Growth Factors Are Strengthening The Medical Device Affairs Outsourcing Market Landscape?
The expanding need for medical devices is projected to fuel the growth of the medical device affairs outsourcing market in the future. Medical devices encompass instruments, apparatuses, machines, or implants utilized for the diagnosis, treatment, or prevention of various medical conditions. This heightened demand for medical devices primarily stems from enhanced treatment effectiveness, better patient results, and the expansion of healthcare facilities. Medical device affairs outsourcing facilitates operational streamlining, strengthens regulatory adherence, and improves market performance, thereby enabling companies to concentrate on innovation and development by leveraging external expertise for crucial functions. For example, in April 2024, The Medicines and Healthcare products Regulatory Agency(MHRA), a UK-based government agency, reported an increase in registered medical products with the MHRA from around 2.25 million in 2022 to around 3.25 million in 2024. Consequently, the rising demand for medical devices is a key factor propelling the medical device affairs outsourcing market.
How Is The Medical Device Affairs Outsourcing Market Distributed Across Key Segments?
The medical device affairs outsourcing market covered in this report is segmented –
1) By Service: Regulatory Writing And Submissions, Regulatory Registration Services, Regulatory Consulting, Other Services
2) By Software: Cloud Based Software, On Premise Software
3) By End User: Pharmaceutical Companies, Medical Technology Companies, Other End Users
Subsegments:
1) By Regulatory Writing And Submissions: Clinical Trial Applications (CTAs), Investigational New Drug Applications (INDs), New Drug Applications (NDAs), Summary And Reports For Regulatory Agencies
2) By Regulatory Registration Services: Device Registration, Market Authorization Applications (MAAs), Product Listing And Establishment Registration
3) By Regulatory Consulting: Strategic Regulatory Planning, Regulatory Compliance Audits, Labeling And Advertising Compliance
4) By Other Services: Post-Market Surveillance, Training And Education, Quality Management System (QMS) Support, Risk Management And Assessment
Which Trends Are Influencing The Direction Of The Medical Device Affairs Outsourcing Market?
Key companies operating in the medical device affairs outsourcing market are concentrating on strengthening decentralized clinical trials to boost the efficiency and flexibility of clinical research, improve patient engagement and retention, and streamline data collection and analysis. A decentralized clinical trial (DCT) refers to a clinical trial framework that supports the medical device sector by offering specialized services that enhance the efficiency, compliance, and effectiveness of clinical trials, which is crucial for bringing novel medical devices to market. For example, in March 2023, Syneos Health, a US-based entity that provides contract research and commercial services to pharmaceuticals and biotechnology, launched a Decentralized Clinical Trial (DCT) Site Network. This initiative was intended to increase the adoption and quality of decentralized clinical trials, reflecting a dedication to advancing decentralized solutions in clinical trials, ultimately improving patient participation and trial outcomes. This integration supports the collection of reliable evidence and real-world insights vital for successful commercialization approaches.
Who Are The Businesses Driving Activity In The Medical Device Affairs Outsourcing Market?
Major companies operating in the medical device affairs outsourcing market are IQVIA Holdings Inc, ICON PLC, PAREXEL International Corporation, Intertek Group PLC, Eurofins Scientific SE, SGS SA, TUV SUD AG, TUV Rheinland AG, UL Solutions Inc, BSI Group, RQM Plus LLC, NAMSA, Medpace Holdings Inc, WuXi AppTec Inc, Charles River Laboratories International Inc, Laboratory Corporation of America Holdings, Sterigenics International LLC, Pace Analytical Services LLC, Avania LLC, Qserve Group BV, IMed Consultancy Ltd, Global Regulatory Partners Inc, MedTech Review LLC, Clario Inc, ProPharma Group Inc, NSF Health Sciences LLC
Access The Complete Medical Device Affairs Outsourcing Market Report:
Which Area Represents The Largest Portion Of The Medical Device Affairs Outsourcing Market?
Europe was the largest region in the medical device affairs outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device affairs outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Medical Device Affairs Outsourcing Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Medical Device Affairs Outsourcing Market 2026, By The Business Research Company
Medical Waste Management Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-waste-management-global-market-report
Medical Lasers Market Report 2026
https://www.thebusinessresearchcompany.com/report/medical-lasers-global-market-report
Urology Medical Lasers Market Report 2026
https://www.thebusinessresearchcompany.com/report/urology-medical-lasers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model